Article Type
Changed
Thu, 08/17/2017 - 10:35
Display Headline
Abdominal pain under immunosuppressive conditions

A 69-year-old diabetic woman with stage 4 non–small-cell lung cancer presented with a 3-day history of abdominal pain and loss of appetite. She was being treated with corticosteroids for a brain metastasis.

Computed tomography (CT) (Figure 1) revealed air within the bladder wall and lumen; diffuse air in the intraperitoneum and retroperitoneum; air distributed from the left iliopsoas muscle to the left femur that spread around the obturator muscle; air in the left ureter; and an abscess in the psoas major muscle extending to the ala of the ilium. A diagnosis of emphysematous cystitis complicated by extensive abdominal emphysema and abscess was made.

Figure 1. Abdominal computed tomography showed emphysematous lesions in the bladder wall and in several other organs in the abdomen, along with an abscess. (A) An image obtained with mediastinal-window settings showed multiple air bubbles with emphysematous changes in the right posterior wall of the urinary bladder (arrow). (B) An image obtained with lung-window settings showed intraperitoneal air (arrows). (C) An image obtained with bone settings showed intraperitoneal and retroperitoneal air (arrows). (D) An image obtained with bone settings showed air in the left femur that had spread around the obturator muscle (arrows). (E) An image obtained with mediastinal-window settings showed an abscess in the psoas major muscle with air (arrows), and another (F) showed the abscess extending to the ala of the ilium.

Blood cultures were negative, but urine cultures grew extended-spectrum beta-lactamase-producing Escherichia coli, which was sensitive to meropenem. Meropenem was given intravenously for 24 days and was stopped when levels of inflammatory markers improved and urine cultures were negative. However, on day 29, the patient developed a fever. Follow-up CT showed that the abscess in the psoas muscle had enlarged (Figure 2). We chose not to surgically drain the abscess because the patient had terminal lung cancer. The patient expired 6 days later, 35 days after her hospital admission.

Figure 2. After cessation of meropenem, computed tomography with mediastinal window settings showed enlargement of the abscess in the psoas major muscle (A, arrowheads) and in front of the ilium (B, arrowheads).

EMPHYSEMATOUS CYSTITIS ASSOCIATED WITH A PSOAS MUSCLE ABSCESS

Emphysematous cystitis is an uncommon urinary tract infection characterized by air within the bladder wall and lumen that is caused by gas-producing pathogens.1,2 The disease is often found in elderly diabetic women. Treatment of emphysematous cystitis typically includes intravenous antibiotics, adequate bladder drainage, and, for diabetic patients, appropriate glycemic control.

Psoas muscle abscess is a collection of pus in the retroperitoneal space.3 It can be primary, caused by hematogenous spread from the site of an occult infection, or secondary, caused by contiguous spread from adjacent infected organs, including those of the urinary tract. Psoas muscle abscess associated with emphysematous cystitis, as in our patient, is rare. We have seen only one other report in the medical literature.4

TREATMENT

The treatment of psoas muscle abscess involves the use of broad-spectrum antibiotics and drainage.5 Small abscesses (less than 3.5 cm) can be controlled with antibiotics alone. Image-guided percutaneous drainage is a safe, minimally invasive option. Surgery is indicated for unsuccessful percutaneous drainage, loculated abscesses, and abscesses difficult to approach percutaneously, or when the underlying disease requires definitive surgical management.

As in our patient, the presence of additional comorbid immunosuppressive conditions2 such as lung cancer and treatment with corticosteroids can allow the infection to become widespread and life-threatening.

References
  1. Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA. Emphysematous cystitis: a review of 135 cases. BJU Int 2007; 100:17–20.
  2. Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine (Baltimore) 2007; 86:47–53.
  3. Mallick IH, Thoufeeq MH, Rajendran TP. Iliopsoas abscesses. Postgrad Med J 2004; 80:459–462.
  4. Choi JK, Kwon JC. Bilateral psoas muscle abscess associated with emphysematous cystitis. Case Rep Med 2015; 2015:285652.
  5. Tabrizian P, Nguyen SQ, Greenstein A, Rajhbeharrysingh U, Divino CM. Management and treatment of iliopsoas abscess. Arch Surg 2009; 144:946–949.
Article PDF
Author and Disclosure Information

Takayo Ota, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masanobu Nakano, MSc
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Noriko Tanaka, MD
Department of Radiology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomohiro Suzumura, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Nozomi Miyatake, BPharm
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Yoshikazu Hasegawa, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomhiro Ozaki, MD
Department of Medical Oncology, Nara Hospital Kinki University Faculty of Medicine, Ikoma, Nara, Japan

Hiroshi Tsukuda, MD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masahiro Fukuoka, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Address: Takayo Ota, MD, PhD, Department of Medical Oncology, Izumi Municipal Hospital, 4-10-10, Fuchu, Izumi, Osaka, 594-0071 Japan; takayo.ota@gmail.com

Issue
Cleveland Clinic Journal of Medicine - 83(12)
Publications
Topics
Page Number
874-875
Legacy Keywords
Lung cancer, immunosuppression, abscess, psoas, Escherichia coli, emphysematous cystitis, Takayo Ota, Masanobu Nakano, Noriko Tanaka, Tomohiro Suzumura, Nozomi Miyatake, Yoshikazu Hasegawa, Tomohiro Oxaki, Hiroshi Tsukuda, Masahiro Fukuoka
Sections
Author and Disclosure Information

Takayo Ota, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masanobu Nakano, MSc
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Noriko Tanaka, MD
Department of Radiology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomohiro Suzumura, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Nozomi Miyatake, BPharm
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Yoshikazu Hasegawa, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomhiro Ozaki, MD
Department of Medical Oncology, Nara Hospital Kinki University Faculty of Medicine, Ikoma, Nara, Japan

Hiroshi Tsukuda, MD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masahiro Fukuoka, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Address: Takayo Ota, MD, PhD, Department of Medical Oncology, Izumi Municipal Hospital, 4-10-10, Fuchu, Izumi, Osaka, 594-0071 Japan; takayo.ota@gmail.com

Author and Disclosure Information

Takayo Ota, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masanobu Nakano, MSc
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Noriko Tanaka, MD
Department of Radiology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomohiro Suzumura, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Nozomi Miyatake, BPharm
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Yoshikazu Hasegawa, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Tomhiro Ozaki, MD
Department of Medical Oncology, Nara Hospital Kinki University Faculty of Medicine, Ikoma, Nara, Japan

Hiroshi Tsukuda, MD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Masahiro Fukuoka, MD, PhD
Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Osaka, Japan

Address: Takayo Ota, MD, PhD, Department of Medical Oncology, Izumi Municipal Hospital, 4-10-10, Fuchu, Izumi, Osaka, 594-0071 Japan; takayo.ota@gmail.com

Article PDF
Article PDF
Related Articles

A 69-year-old diabetic woman with stage 4 non–small-cell lung cancer presented with a 3-day history of abdominal pain and loss of appetite. She was being treated with corticosteroids for a brain metastasis.

Computed tomography (CT) (Figure 1) revealed air within the bladder wall and lumen; diffuse air in the intraperitoneum and retroperitoneum; air distributed from the left iliopsoas muscle to the left femur that spread around the obturator muscle; air in the left ureter; and an abscess in the psoas major muscle extending to the ala of the ilium. A diagnosis of emphysematous cystitis complicated by extensive abdominal emphysema and abscess was made.

Figure 1. Abdominal computed tomography showed emphysematous lesions in the bladder wall and in several other organs in the abdomen, along with an abscess. (A) An image obtained with mediastinal-window settings showed multiple air bubbles with emphysematous changes in the right posterior wall of the urinary bladder (arrow). (B) An image obtained with lung-window settings showed intraperitoneal air (arrows). (C) An image obtained with bone settings showed intraperitoneal and retroperitoneal air (arrows). (D) An image obtained with bone settings showed air in the left femur that had spread around the obturator muscle (arrows). (E) An image obtained with mediastinal-window settings showed an abscess in the psoas major muscle with air (arrows), and another (F) showed the abscess extending to the ala of the ilium.

Blood cultures were negative, but urine cultures grew extended-spectrum beta-lactamase-producing Escherichia coli, which was sensitive to meropenem. Meropenem was given intravenously for 24 days and was stopped when levels of inflammatory markers improved and urine cultures were negative. However, on day 29, the patient developed a fever. Follow-up CT showed that the abscess in the psoas muscle had enlarged (Figure 2). We chose not to surgically drain the abscess because the patient had terminal lung cancer. The patient expired 6 days later, 35 days after her hospital admission.

Figure 2. After cessation of meropenem, computed tomography with mediastinal window settings showed enlargement of the abscess in the psoas major muscle (A, arrowheads) and in front of the ilium (B, arrowheads).

EMPHYSEMATOUS CYSTITIS ASSOCIATED WITH A PSOAS MUSCLE ABSCESS

Emphysematous cystitis is an uncommon urinary tract infection characterized by air within the bladder wall and lumen that is caused by gas-producing pathogens.1,2 The disease is often found in elderly diabetic women. Treatment of emphysematous cystitis typically includes intravenous antibiotics, adequate bladder drainage, and, for diabetic patients, appropriate glycemic control.

Psoas muscle abscess is a collection of pus in the retroperitoneal space.3 It can be primary, caused by hematogenous spread from the site of an occult infection, or secondary, caused by contiguous spread from adjacent infected organs, including those of the urinary tract. Psoas muscle abscess associated with emphysematous cystitis, as in our patient, is rare. We have seen only one other report in the medical literature.4

TREATMENT

The treatment of psoas muscle abscess involves the use of broad-spectrum antibiotics and drainage.5 Small abscesses (less than 3.5 cm) can be controlled with antibiotics alone. Image-guided percutaneous drainage is a safe, minimally invasive option. Surgery is indicated for unsuccessful percutaneous drainage, loculated abscesses, and abscesses difficult to approach percutaneously, or when the underlying disease requires definitive surgical management.

As in our patient, the presence of additional comorbid immunosuppressive conditions2 such as lung cancer and treatment with corticosteroids can allow the infection to become widespread and life-threatening.

A 69-year-old diabetic woman with stage 4 non–small-cell lung cancer presented with a 3-day history of abdominal pain and loss of appetite. She was being treated with corticosteroids for a brain metastasis.

Computed tomography (CT) (Figure 1) revealed air within the bladder wall and lumen; diffuse air in the intraperitoneum and retroperitoneum; air distributed from the left iliopsoas muscle to the left femur that spread around the obturator muscle; air in the left ureter; and an abscess in the psoas major muscle extending to the ala of the ilium. A diagnosis of emphysematous cystitis complicated by extensive abdominal emphysema and abscess was made.

Figure 1. Abdominal computed tomography showed emphysematous lesions in the bladder wall and in several other organs in the abdomen, along with an abscess. (A) An image obtained with mediastinal-window settings showed multiple air bubbles with emphysematous changes in the right posterior wall of the urinary bladder (arrow). (B) An image obtained with lung-window settings showed intraperitoneal air (arrows). (C) An image obtained with bone settings showed intraperitoneal and retroperitoneal air (arrows). (D) An image obtained with bone settings showed air in the left femur that had spread around the obturator muscle (arrows). (E) An image obtained with mediastinal-window settings showed an abscess in the psoas major muscle with air (arrows), and another (F) showed the abscess extending to the ala of the ilium.

Blood cultures were negative, but urine cultures grew extended-spectrum beta-lactamase-producing Escherichia coli, which was sensitive to meropenem. Meropenem was given intravenously for 24 days and was stopped when levels of inflammatory markers improved and urine cultures were negative. However, on day 29, the patient developed a fever. Follow-up CT showed that the abscess in the psoas muscle had enlarged (Figure 2). We chose not to surgically drain the abscess because the patient had terminal lung cancer. The patient expired 6 days later, 35 days after her hospital admission.

Figure 2. After cessation of meropenem, computed tomography with mediastinal window settings showed enlargement of the abscess in the psoas major muscle (A, arrowheads) and in front of the ilium (B, arrowheads).

EMPHYSEMATOUS CYSTITIS ASSOCIATED WITH A PSOAS MUSCLE ABSCESS

Emphysematous cystitis is an uncommon urinary tract infection characterized by air within the bladder wall and lumen that is caused by gas-producing pathogens.1,2 The disease is often found in elderly diabetic women. Treatment of emphysematous cystitis typically includes intravenous antibiotics, adequate bladder drainage, and, for diabetic patients, appropriate glycemic control.

Psoas muscle abscess is a collection of pus in the retroperitoneal space.3 It can be primary, caused by hematogenous spread from the site of an occult infection, or secondary, caused by contiguous spread from adjacent infected organs, including those of the urinary tract. Psoas muscle abscess associated with emphysematous cystitis, as in our patient, is rare. We have seen only one other report in the medical literature.4

TREATMENT

The treatment of psoas muscle abscess involves the use of broad-spectrum antibiotics and drainage.5 Small abscesses (less than 3.5 cm) can be controlled with antibiotics alone. Image-guided percutaneous drainage is a safe, minimally invasive option. Surgery is indicated for unsuccessful percutaneous drainage, loculated abscesses, and abscesses difficult to approach percutaneously, or when the underlying disease requires definitive surgical management.

As in our patient, the presence of additional comorbid immunosuppressive conditions2 such as lung cancer and treatment with corticosteroids can allow the infection to become widespread and life-threatening.

References
  1. Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA. Emphysematous cystitis: a review of 135 cases. BJU Int 2007; 100:17–20.
  2. Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine (Baltimore) 2007; 86:47–53.
  3. Mallick IH, Thoufeeq MH, Rajendran TP. Iliopsoas abscesses. Postgrad Med J 2004; 80:459–462.
  4. Choi JK, Kwon JC. Bilateral psoas muscle abscess associated with emphysematous cystitis. Case Rep Med 2015; 2015:285652.
  5. Tabrizian P, Nguyen SQ, Greenstein A, Rajhbeharrysingh U, Divino CM. Management and treatment of iliopsoas abscess. Arch Surg 2009; 144:946–949.
References
  1. Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA. Emphysematous cystitis: a review of 135 cases. BJU Int 2007; 100:17–20.
  2. Grupper M, Kravtsov A, Potasman I. Emphysematous cystitis: illustrative case report and review of the literature. Medicine (Baltimore) 2007; 86:47–53.
  3. Mallick IH, Thoufeeq MH, Rajendran TP. Iliopsoas abscesses. Postgrad Med J 2004; 80:459–462.
  4. Choi JK, Kwon JC. Bilateral psoas muscle abscess associated with emphysematous cystitis. Case Rep Med 2015; 2015:285652.
  5. Tabrizian P, Nguyen SQ, Greenstein A, Rajhbeharrysingh U, Divino CM. Management and treatment of iliopsoas abscess. Arch Surg 2009; 144:946–949.
Issue
Cleveland Clinic Journal of Medicine - 83(12)
Issue
Cleveland Clinic Journal of Medicine - 83(12)
Page Number
874-875
Page Number
874-875
Publications
Publications
Topics
Article Type
Display Headline
Abdominal pain under immunosuppressive conditions
Display Headline
Abdominal pain under immunosuppressive conditions
Legacy Keywords
Lung cancer, immunosuppression, abscess, psoas, Escherichia coli, emphysematous cystitis, Takayo Ota, Masanobu Nakano, Noriko Tanaka, Tomohiro Suzumura, Nozomi Miyatake, Yoshikazu Hasegawa, Tomohiro Oxaki, Hiroshi Tsukuda, Masahiro Fukuoka
Legacy Keywords
Lung cancer, immunosuppression, abscess, psoas, Escherichia coli, emphysematous cystitis, Takayo Ota, Masanobu Nakano, Noriko Tanaka, Tomohiro Suzumura, Nozomi Miyatake, Yoshikazu Hasegawa, Tomohiro Oxaki, Hiroshi Tsukuda, Masahiro Fukuoka
Sections
Disallow All Ads
Alternative CME
Article PDF Media